Re: Rough Transcript - Resverlogix Corporate Update and Conference Call - 06/10/2020
posted on
Jun 11, 2020 02:44PM
Combination:
All patients in BETonMACE were on a statin.
Those on Apabetalone are taking a combo of statin and apabetalone.
Some of above are also on SGLT2i or DPP4i, which would comprise a triple combo.
And if those above are on both SGLT2i and DPP4i would be a quadruple combo.
Thus far, no info on SGLT2i or DPP4 usage in the CKD subgroup. The MACE data for the CKD subgroup is for all CKD patients on statin plus/minus apabetalone.
BDAZ